Pregnancy and lactation-associated osteoporosis: a rare cause of postpartum lower back pain (#41)
5:00 PM
Postprandial Walking as a Potential Non-Pharmacological Treatment for Women with Gestational Diabetes Mellitus (GDM): A Pilot Study (#42)
5:00 PM
Pilot study of dietary intake, knowledge, attitudes and beliefs of women with gestational diabetes following initial group nutrition education. (#43)
5:00 PM
Management and Outcomes in Pregnancies Complicated by Type 1 Diabetes Mellitus: A 4 year Audit of Practice (#44)
5:00 PM
How has changing the diagnostic criteria for GDM impacted perinatal outcomes in Queensland? (#45)
5:00 PM
The prevalence of non-alcoholic fatty liver detected by FibroScan® in pregnant women at risk of developing gestational diabetes in a multiethnic population in Western Sydney (#46)
5:00 PM
Investigating the role of the pharmacist in contraception and pre-pregnancy care for women with Type 1 and Type 2 diabetes in South West Sydney: patient and pharmacist perspectives (#47)
5:00 PM
A Tale of Two Diabetes: Pregnant Woman with Diabetes Insipidus and Gestational Diabetes – A Case Report (#48)
5:00 PM
Complexities with diagnosis: A rare cause of diabetes mellitus in pregnancy (#49)
5:00 PM
No Suggestion of Interventricular Wall Hypertrophy in Infants Born to Diabetic Mothers Compared to Controls (#50)
5:00 PM
Slipping Through the Cracks: Misconceptions of Pregnancy Oral Glucose Tolerance Testing in Women Prescribed Corticosteroids during Pregnancy (#51)
5:00 PM
Aspirin may protect from pre-eclampsia in women with pre-existing diabetes and additional risk factors, but increases the risk of post-partum haemorrhage (#52)
5:00 PM
Estimating true prevalence of gestational diabetes in New Zealand: commonly used data sources result in significant variation (#53)
5:00 PM
Utility of continuous glucose monitoring and flash glucose monitoring for pregnant women with diabetes mellitus after steroid administration? (#54)
5:00 PM
Retrospective Audit of Obstetric Data: Prevalence and impact of obesity in early pregnancy in rural NW Tasmania (#55)
5:00 PM
Nutrient intake, carbohydrate counting and self-management skills in pregnant women with Type 1 Diabetes Mellitus (#56)
5:00 PM
The usefulness (or uselessness) of HbA1c for women tested early in pregnancy for GDM. (#57)
5:00 PM
Multidisciplinary Care for Women with Diabetes in Pregnancy-are the services we are providing women actually improving maternal, foetal, neonatal and childhood health and wellbeing outcomes? (#58)
5:00 PM
Perceptions of risk and experiences of gestational diabetes mellitus among Australian Samoan women in South Western Sydney. (#59)
5:00 PM
A Retrospective Audit of the Efficacy of New Glycaemic Targets in the Treatment of Gestational Diabetes Mellitus (GDM) in the Sunshine Coast Hospital and Health Service District (SCHHS) (#60)
5:00 PM
Investigating The Link Between Depression and Gestational Diabetes In Rural Australia (#61)
5:00 PM
Oral glucose tolerance testing in pregnancy and impact on perinatal outcomes (#62)
5:00 PM
Reduction in pregnancy risk among young women with diabetes in a transition diabetes clinic (#63)
5:00 PM
e-patients with sugar babies: How women diagnosed with gestational diabetes mellitus self-manage and experience support using the internet, social media and apps (#64)
5:00 PM
Insulin isophane allergy in gestational diabetes mellitus. (#65)
5:00 PM
Associations of late third trimester HbA1c with adverse pregnancy outcomes in women with gestational diabetes. (#66)
5:00 PM
Ketonuria is associated with changes to the abundance of Roseburia in the gut microbiota of overweight and obese women at 16 weeks gestation. (#67)
5:00 PM
The impact of pre-pregnancy weight modulation on placental structure and inflammation in mouse models of diabetes and obesity (#68)
5:00 PM
An insulin infusion designed for pregnancy provides comparable glycaemic control following betamethasone in women with gestational and pre-existing diabetes, although hypoglycaemia is more common in pre-existing diabetes (#69)
5:00 PM
Transient extreme insulin resistance in pregnancy following betamethasone administration managed with high-dose intravenous insulin: case series and literature review. (#70)
5:00 PM
Preconception weight loss therapy improves pregnancy outcomes and reduces kidney-related adverse effects of maternal obesity (#71)
5:00 PM
An early pregnancy HbA1c ≥5.9% (41 mmol/mol) is not a valid biomarker for early or late gestational diabetes mellitus and does not predict adverse pregnancy outcomes in obese pregnant women (#72)
5:00 PM
Relationship between sleep and snoring and body mass index among women with risk factors for gestational diabetes mellitus at booking: Preliminary findings from a multicentre randomized trial (#73)
5:00 PM
Evaluation of the Diabetes Contraception and Pre-pregnancy Program (DCAPP) in General Practice. (#74)
5:00 PM
Caring for women with Type 1 and Type 2 diabetes in pregnancy on the Coast- a model of care. (#75)
5:00 PM
Difficulties with the follow-up of women with GDM (#76)
5:00 PM
Implementation of an integrated, district-wide Diabetes Contraception and Pre-pregnancy Program (DCAPP) among women with Type 1 and 2 diabetes: an update (#77)
5:00 PM
The I in IOL is rapidly becoming GDM-I - An audit of induction of labour at a tertiary metropolitan hospital in Western Australia (#78)
5:00 PM
Impact of changes in diagnostic criteria for gestational diabetes on maternal characteristics and pregnancy outcomes (#79)
5:00 PM
Qualitative investigation into culturally appropriate gestational diabetes mellitus care: providers’ and patients’ perspectives (#80)
5:00 PM
Can risk prediction calculators be used to inform models of care aligned to risk stratification in women with GDM? (#81)
5:00 PM
Psychosocial Wellbeing among New Mothers with Diabetes: Analysis of the Postnatal Wellbeing in Transition Questionnaire (#82)
5:00 PM
Gestational Diabetes in the ACT: Continuing to Grow (#83)
5:00 PM
Factors that drive behaviour change in women diagnosed with Gestational Diabetes Mellitus at the Royal Women’s Hospital (#84)
5:00 PM